Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 6 studies | 28% ± 11% | |
plasmacytoid dendritic cell | 4 studies | 21% ± 5% | |
CD8-positive, alpha-beta T cell | 4 studies | 21% ± 9% | |
plasmablast | 3 studies | 41% ± 15% | |
CD4-positive, alpha-beta T cell | 3 studies | 16% ± 1% | |
conventional dendritic cell | 3 studies | 24% ± 8% | |
hematopoietic precursor cell | 3 studies | 21% ± 3% | |
non-classical monocyte | 3 studies | 19% ± 3% | |
retinal ganglion cell | 3 studies | 59% ± 22% | |
ciliated cell | 3 studies | 33% ± 3% | |
macrophage | 3 studies | 21% ± 4% | |
dendritic cell | 3 studies | 25% ± 6% |
Insufficient scRNA-seq data for expression of SLX9 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1070.67 | 1445 / 1445 | 100% | 26.66 | 183 / 183 |
ovary | 100% | 479.84 | 180 / 180 | 100% | 40.75 | 430 / 430 |
skin | 100% | 1029.01 | 1808 / 1809 | 100% | 56.16 | 472 / 472 |
liver | 100% | 658.77 | 226 / 226 | 100% | 25.48 | 404 / 406 |
uterus | 100% | 656.44 | 170 / 170 | 99% | 40.39 | 456 / 459 |
intestine | 100% | 983.45 | 966 / 966 | 99% | 34.72 | 523 / 527 |
prostate | 100% | 628.36 | 244 / 245 | 99% | 29.21 | 498 / 502 |
thymus | 99% | 474.61 | 648 / 653 | 100% | 25.31 | 602 / 605 |
stomach | 100% | 695.11 | 359 / 359 | 99% | 33.89 | 282 / 286 |
kidney | 100% | 653.58 | 89 / 89 | 98% | 22.80 | 887 / 901 |
bladder | 100% | 1236.33 | 21 / 21 | 98% | 35.03 | 495 / 504 |
brain | 98% | 557.84 | 2586 / 2642 | 100% | 28.45 | 705 / 705 |
lung | 99% | 626.36 | 571 / 578 | 98% | 26.85 | 1137 / 1155 |
breast | 100% | 767.47 | 458 / 459 | 97% | 29.15 | 1088 / 1118 |
pancreas | 98% | 472.48 | 320 / 328 | 99% | 25.36 | 177 / 178 |
adrenal gland | 100% | 791.72 | 258 / 258 | 97% | 25.94 | 223 / 230 |
blood vessel | 100% | 1992.31 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 88.07 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 95.81 | 29 / 29 |
spleen | 100% | 1030.01 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 35.74 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 9.18 | 1 / 1 |
adipose | 100% | 757.32 | 1200 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 1025.30 | 799 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 981.84 | 846 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 88% | 577.60 | 818 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000462 | Biological process | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) |
GO_0005730 | Cellular component | nucleolus |
GO_0030688 | Cellular component | preribosome, small subunit precursor |
GO_0030686 | Cellular component | 90S preribosome |
GO_0005515 | Molecular function | protein binding |
Gene name | SLX9 |
Protein name | SLX9 ribosome biogenesis factor Ribosome biogenesis protein SLX9 homolog |
Synonyms | C21orf70 PRED56 FAM207A |
Description | FUNCTION: May be involved in ribosome biogenesis. . |
Accessions | Q9NSI2 ENST00000291634.11 [Q9NSI2-1] ENST00000397826.8 [Q9NSI2-2] C9JJU7 ENST00000458015.1 |